STIM1 and breast carcinoma: To further assess Tam’s role on progestin-mediated PR/AP-1 complex formation and breast cancer growth, we used BT474 breast cancer cells which express ERα and PR, overexpress ErbB-2, and are fully resistant to Tam antiproliferative effects[61].